{"id":49089,"date":"2022-10-03T16:01:48","date_gmt":"2022-10-03T14:01:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/"},"modified":"2022-10-03T16:01:48","modified_gmt":"2022-10-03T14:01:48","slug":"statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/","title":{"rendered":"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now"},"content":{"rendered":"<div>\n<p>BETHESDA, Md.&#8211;(BUSINESS WIRE)&#8211;The events of the past week have led to significant concern and conversation about Tua Tagovailoa\u2019s health and recovery and have highlighted the need for changes to the NFL\u2019s concussion protocols. When a player hits his head and is visibly shaken and potentially even collapses, this is a good indication that there is a disruption to brain function. However, misinterpretation of subjective evaluations and self-reporting of symptoms can and do lead to inaccurate conclusions.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/5\/BrainScope_Logo_final.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/21\/BrainScope_Logo_final.jpg\"><\/a><\/p>\n<p>\nIncorporating objective evidence into the evaluation of head injury could greatly improve clinical diagnosis, return to play decision-making and ultimately, outcomes. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fbrainscope.com%2F&amp;esheet=52934251&amp;newsitemid=20221003005308&amp;lan=en-US&amp;anchor=BrainScope%26%238217%3Bs&amp;index=1&amp;md5=6be784de3853131b64e0f8f94ac5b4f8\" rel=\"nofollow noopener\" shape=\"rect\">BrainScope\u2019s<\/a> handheld device provides FDA cleared indications for both the likelihood of concussion and brain bleed at the same time, without radiation and in minutes. The highly validated assessment results provide physicians with objective information that aids in making an informed and accurate diagnosis.\n<\/p>\n<p>\nWith millions of head injuries in the U.S. each year, it is time to integrate objective biomarkers of injury into clinical diagnosis.\n<\/p>\n<p>\n<b>About BrainScope<\/b>\n<\/p>\n<p>\nBrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. BrainScope is leading the way in the rapid and objective assessment of brain-related conditions, starting with mild traumatic brain injury (mTBI), utilizing multiple integrated assessment capabilities, artificial intelligence (AI), and digitization. The company\u2019s technology supports the American College of Emergency Physicians (ACEP) Choosing Wisely\u00ae campaign to avoid CT scans of the head in emergency department patients with minor head injury. BrainScope\u2019s innovative brain electrical activity-based, AI-derived algorithms empower physicians to quickly make accurate head injury assessments, addressing the full spectrum of traumatic brain injuries from structural (brain bleed) to functional (concussion) injuries, providing for the first time a full picture of the injury, and doing so in less time and without radiation. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.brainscope.com&amp;esheet=52934251&amp;newsitemid=20221003005308&amp;lan=en-US&amp;anchor=www.brainscope.com&amp;index=2&amp;md5=bfb5a3507bfa28aaa552390118e3c6e4\" rel=\"nofollow noopener\" shape=\"rect\">www.brainscope.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nCherie Lucier<br \/>\n<br \/>Chief Experience Officer<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;t&#x6f;&#x3a;&#x63;&#104;er&#x69;&#x65;&#46;&#108;u&#x63;&#x69;&#x65;&#114;&#64;b&#x72;&#x61;&#105;&#110;s&#x63;&#x6f;&#x70;&#101;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x63;&#104;e&#x72;&#105;e&#x2e;&#x6c;&#117;&#x63;&#x69;&#101;r&#x40;&#98;r&#x61;&#x69;&#110;&#x73;&#x63;&#111;p&#x65;&#46;c&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BETHESDA, Md.&#8211;(BUSINESS WIRE)&#8211;The events of the past week have led to significant concern and conversation about Tua Tagovailoa\u2019s health and recovery and have highlighted the need for changes to the NFL\u2019s concussion protocols. When a player hits his head and is visibly shaken and potentially even collapses, this is a good indication that there is &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49089","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BETHESDA, Md.&#8211;(BUSINESS WIRE)&#8211;The events of the past week have led to significant concern and conversation about Tua Tagovailoa\u2019s health and recovery and have highlighted the need for changes to the NFL\u2019s concussion protocols. When a player hits his head and is visibly shaken and potentially even collapses, this is a good indication that there is ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-03T14:01:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/21\/BrainScope_Logo_final.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now\",\"datePublished\":\"2022-10-03T14:01:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/\"},\"wordCount\":344,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005308\\\/en\\\/1440334\\\/21\\\/BrainScope_Logo_final.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/\",\"name\":\"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005308\\\/en\\\/1440334\\\/21\\\/BrainScope_Logo_final.jpg\",\"datePublished\":\"2022-10-03T14:01:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005308\\\/en\\\/1440334\\\/21\\\/BrainScope_Logo_final.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005308\\\/en\\\/1440334\\\/21\\\/BrainScope_Logo_final.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/","og_locale":"en_US","og_type":"article","og_title":"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now - Pharma Trend","og_description":"BETHESDA, Md.&#8211;(BUSINESS WIRE)&#8211;The events of the past week have led to significant concern and conversation about Tua Tagovailoa\u2019s health and recovery and have highlighted the need for changes to the NFL\u2019s concussion protocols. When a player hits his head and is visibly shaken and potentially even collapses, this is a good indication that there is ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-03T14:01:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/21\/BrainScope_Logo_final.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now","datePublished":"2022-10-03T14:01:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/"},"wordCount":344,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/21\/BrainScope_Logo_final.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/","url":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/","name":"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/21\/BrainScope_Logo_final.jpg","datePublished":"2022-10-03T14:01:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/21\/BrainScope_Logo_final.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221003005308\/en\/1440334\/21\/BrainScope_Logo_final.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/statement-from-brainscope-tua-tagovailoas-injury-and-why-we-need-a-more-objective-assessment-of-head-injuries-now\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Statement from BrainScope: Tua Tagovailoa\u2019s Injury and Why We Need a More Objective Assessment of Head Injuries Now"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49089"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49089\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}